Stockscreener 앱 받기
0.825
8.77%
0.0665
Acurx Pharmaceuticals Inc (ACXP) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Operating Expenses
|
14.40%
4.3779
|
5.1146 | 3.115 | 3.4452 | 2.903 |
| Income/Loss From Continuing Operations Before Tax |
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
| Income/Loss From Continuing Operations After Tax |
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
|
Net Income/Loss
|
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,872%
15.47
|
0.3896 | 13.01 | 12.19 | 11.64 |
| Diluted Average Shares |
3,872%
15.47
|
0.3896 | 13.01 | 12.19 | 11.64 |
| Basic Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.24 | -0.28 | -0.25 |
| Diluted Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.24 | -0.28 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
자본화:
|
볼륨(24시간):